1-16 of 16
Bonnie S. Glisson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma

Kevin J. Contrera, Renata Ferrarotto, Brandon Gunn, Shirley Y. Su, Merrill S. Kies, Bonnie S. Glisson, Adam S. Garden, Dianna Roberts, Curtis Hanba, Camilla O. Hoff, Adel El-Naggar, Michelle D. Williams, Shaan M. Raza, Franco DeMonte, Melissa M. Chen, Mark S. Chambers, Ehab Y. Hanna
Journal: Clinical Cancer Research
Clin Cancer Res (2024)
https://doi.org/10.1158/1078-0432.CCR-24-1416
Published: 12 November 2024
View article titled, Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma
Open the PDF for Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

Renata Ferrarotto, Yoshitsugu Mitani, Daniel J. McGrail, Kaiyi Li, Tatiana V. Karpinets, Diana Bell, Steven J. Frank, Xingzhi Song, Michael E. Kupferman, Bin Liu, J. Jack Lee, Bonnie S. Glisson, Jianhua Zhang, Jon C. Aster, Shiaw-Yih Lin, P. Andrew Futreal, John V. Heymach, Adel K. El-Naggar
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (14): 2737.
https://doi.org/10.1158/1078-0432.CCR-23-1697
Published: 14 July 2023
View article titled, Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Open the PDF for Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets in another window
Journal Articles

Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

Renata Ferrarotto, Yoshitsugu Mitani, Daniel J. McGrail, Kaiyi Li, Tatiana V. Karpinets, Diana Bell, Steven J. Frank, Xingzhi Song, Michael E. Kupferman, Bin Liu, J. Jack Lee, Bonnie S. Glisson, Jianhua Zhang, Jon C. Aster, Shiaw-Yih Lin, P. Andrew Futreal, John V. Heymach, Adel K. El-Naggar
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (3): 852–864.
https://doi.org/10.1158/1078-0432.CCR-20-1192
Published: 01 February 2023
View article titled, Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Open the PDF for Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets in another window
Includes: Supplementary data
Journal Articles

Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, M. Laura Rubin, Ying Yuan, Diana Bell, Adel K. El-Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Charles Lu, Frank E. Mott, Bita Esmaeli, Eduardo M. Diaz, Jr, Paul W. Gidley, Ryan P. Goepfert, Carol M. Lewis, Randal S. Weber, Jennifer A. Wargo, Sreyashi Basu, Fei Duan, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1735.
https://doi.org/10.1158/1078-0432.CCR-22-0468
Published: 14 April 2022
View article titled, Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, M. Laura Rubin, Ying Yuan, Diana Bell, Adel K. El-Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Charles Lu, Frank E. Mott, Bita Esmaeli, Eduardo M. Diaz, Jr, Paul W. Gidley, Ryan P. Goepfert, Carol M. Lewis, Randal S. Weber, Jennifer A. Wargo, Sreyashi Basu, Fei Duan, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4557–4565.
https://doi.org/10.1158/1078-0432.CCR-21-0585
Published: 15 August 2021
View article titled, Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Bonnie S. Glisson, Rom S. Leidner, Robert L. Ferris, John Powderly, Naiyer A. Rizvi, Bhumsuk Keam, Reva Schneider, Sanjay Goel, James P. Ohr, Jennifer Burton, Yanan Zheng, Steven Eck, Matthew Gribbin, Katie Streicher, Danielle M. Townsley, Sandip Pravin Patel
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5358–5367.
https://doi.org/10.1158/1078-0432.CCR-19-3070
Published: 15 October 2020
View article titled, Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
Open the PDF for Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results

Renata Ferrarotto, Diana Bell, Maria L. Rubin, Katherine A. Hutcheson, Jason M. Johnson, Ryan P. Goepfert, Jack Phan, Yasir Y. Elamin, Danice K. Torman, Carla L. Warneke, Amy C. Hessel, Adam S. Garden, Jeffrey N. Myers, Faye M. Johnson, J. Jack Lee, Andrew G. Sikora, Maura L. Gillison, Bonnie S. Glisson, Neil D. Gross
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13): 3211–3219.
https://doi.org/10.1158/1078-0432.CCR-19-3977
Published: 01 July 2020
View article titled, Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8<sup>+</sup> Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
Open the PDF for Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8<sup>+</sup> Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results in another window
Includes: Supplementary data
Journal Articles

The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma

Minglei Zhuo, Yanfang Guan, Xue Yang, Lingzhi Hong, Yuqi Wang, Zhongwu Li, Runzhe Chen, Hussein A. Abbas, Lianpeng Chang, Yuhua Gong, Nan Wu, Jia Zhong, Wenting Chen, Hanxiao Chen, Zhi Dong, Xiang Zhu, Jianjie Li, Yuyan Wang, Tongtong An, Meina Wu, Ziping Wang, Jiayin Wang, Emily B. Roarty, Waree Rinsurongkawong, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, John V. Heymach, Ignacio I. Wistuba, Neda Kalhor, Ling Yang, Xin Yi, P. Andrew Futreal, Bonnie S. Glisson, Xuefeng Xia, Jianjun Zhang, Jun Zhao
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (4): 892–901.
https://doi.org/10.1158/1078-0432.CCR-19-0556
Published: 14 February 2020
View article titled, The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma
Open the PDF for The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study

Daniel Morgensztern, Benjamin Besse, Laurent Greillier, Rafael Santana-Davila, Neal Ready, Christine L. Hann, Bonnie S. Glisson, Anna F. Farago, Afshin Dowlati, Charles M. Rudin, Sylvestre Le Moulec, Satwant Lally, Sreeni Yalamanchili, Jürgen Wolf, Ramaswamy Govindan, David P. Carbone
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (23): 6958–6966.
https://doi.org/10.1158/1078-0432.CCR-19-1133
Published: 02 December 2019
View article titled, Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study
Open the PDF for Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study in another window
Includes: Supplementary data
Journal Articles

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC

Xiuning Le, Sonam Puri, Marcelo V. Negrao, Monique B. Nilsson, Jacqulyne Robichaux, Theresa Boyle, J. Kevin Hicks, Katherine L. Lovinger, Emily Roarty, Waree Rinsurongkawong, Ming Tang, Huiying Sun, Yasir Elamin, Lara C. Lacerda, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, William N. William, Jr, Bonnie S. Glisson, Jianjun Zhang, Vassiliki A. Papadimitrakopoulou, Jhanelle E. Gray, John V. Heymach
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6195–6203.
https://doi.org/10.1158/1078-0432.CCR-18-1542
Published: 13 December 2018
View article titled, Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <em>EGFR</em>-Mutant NSCLC
Open the PDF for Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <em>EGFR</em>-Mutant NSCLC in another window
Includes: Supplementary data
Journal Articles

Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer

Renata Ferrarotto, Ruchitha Goonatilake, Suk Young Yoo, Pan Tong, Uma Giri, Shaohua Peng, John Minna, Luc Girard, Yuehong Wang, Liguang Wang, Lerong Li, Lixia Diao, David H. Peng, Don L. Gibbons, Bonnie S. Glisson, John V. Heymach, Jing Wang, Lauren A. Byers, Faye M. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (7): 1674–1686.
https://doi.org/10.1158/1078-0432.CCR-14-2890
Published: 31 March 2016
View article titled, Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
Open the PDF for Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

New Strategies in Human Papillomavirus–Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic

Erminia Massarelli, Renata Ferrarotto, Bonnie S. Glisson
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3821–3828.
https://doi.org/10.1158/1078-0432.CCR-14-1329
Published: 31 August 2015
View article titled, New Strategies in Human Papillomavirus–Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic
Open the PDF for New Strategies in Human Papillomavirus–Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic in another window
Journal Articles

A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck

Carol M. Lewis, Bonnie S. Glisson, Lei Feng, Fiona Wan, Ximing Tang, Ignacio I. Wistuba, Adel K. El-Naggar, David I. Rosenthal, Mark S. Chambers, Robert A. Lustig, Randal S. Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1435–1446.
https://doi.org/10.1158/1078-0432.CCR-11-1951
Published: 01 March 2012
View article titled, A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck
Open the PDF for A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Paclitaxel in Solid Tumors

Fadlo R. Khuri, Bonnie S. Glisson, Edward S. Kim, Paul Statkevich, Peter F. Thall, Michael L. Meyers, Roy S. Herbst, Reginald F. Munden, Craig Tendler, Yali Zhu, Sandra Bangert, Elizabeth Thompson, Charles Lu, Xue-Mei Wang, Dong M. Shin, Merrill S. Kies, Vali Papadimitrakopoulou, Frank V. Fossella, Paul Kirschmeier, W. Robert Bishop, Waun Ki Hong
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (9): 2968–2976.
https://doi.org/10.1158/1078-0432.CCR-03-0412
Published: 06 May 2004
View article titled, Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Paclitaxel in Solid Tumors
Open the PDF for Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Paclitaxel in Solid Tumors in another window
Journal Articles

A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer

Charles Lu, Ritsuko Komaki, Jin Soo Lee, Dong M. Shin, J. Lynn Palmer, Brenda J. Coldman, Katherine M. Pisters, Jonathan M. Kurie, Frank V. Fossella, Bonnie S. Glisson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2085–2091.
Published: 01 June 2003
View article titled, A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer
Open the PDF for A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer in another window
Journal Articles

Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer

Dong M. Shin, Nicholas J. Donato, Roman Perez-Soler, Hyung Ju C. Shin, Ji Y. Wu, Peter Zhang, Kristie Lawhorn, Fadlo R. Khuri, Bonnie S. Glisson, Jeffrey Myers, Gary Clayman, David Pfister, John Falcey, Harlan Waksal, John Mendelsohn, Waun Ki Hong
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1204–1213.
Published: 01 May 2001
View article titled, Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer
Open the PDF for Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer in another window